• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE DEFIBRILLATOR LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE G; IMPLANTABLE DEFIBRILLATOR LEAD Back to Search Results
Model Number 0174
Medical Device Problem Codes High impedance (1291); High Capture Threshold (3266)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/25/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this right ventricular (rv) lead was explanted and replaced.The lead exhibited pacing impedance gradually increasing, as well as, pacing thresholds which also gradually increased.The lead was confirmed to have fracture.No adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead was explanted and replaced.The lead exhibited pacing impedance gradually increasing, as well as, pacing thresholds which also gradually increased.No adverse patient effects were reported.
 
Event or Problem Description
It was reported that this right ventricular (rv) lead was explanted and replaced.The lead exhibited pacing impedance gradually increasing, as well as, pacing thresholds which also gradually increased.No adverse patient effects were reported.
 
Additional Manufacturer Narrative
The device was not returned for analysis; therefore, a technical analysis could not be performed.Good faith effort attempts were made to try and retrieve the device, however a response was not received.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE G
Common Device Name
IMPLANTABLE DEFIBRILLATOR LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
#12, rd. #698
dorado PR 00646
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key23750897
Report Number2124215-2025-89666
Device Sequence Number18471845
Product Code LWS
UDI-Device Identifier00802526373640
UDI-Public(01)00802526373640(17)100124
Combination Product (Y/N)Y
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P910073
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Device Explanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/24/2010
Device Model Number0174
Device Catalogue Number0174
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/25/2025
Supplement Date Received by Manufacturer03/02/2026
04/10/2026
Initial Report FDA Received Date12/08/2025
Supplement Report FDA Received Date03/02/2026
04/14/2026
Date Device Manufactured01/24/2008
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age82 YR
Patient SexFemale
-
-